Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET Pharmaceutical Investing
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference Life Science Investing
Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Life Science Investing
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States Pharmaceutical Investing
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension Life Science Investing
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference Pharmaceutical Investing
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha -Thalassemia Life Science Investing
